ATBPF
Price
$0.22
Change
+$0.03 (+15.79%)
Updated
Apr 8 closing price
KMSTF
Price
$6.40
Change
-$0.10 (-1.54%)
Updated
Mar 12 closing price
Ad is loading...

ATBPF vs KMSTF

Header iconATBPF vs KMSTF Comparison
Open Charts ATBPF vs KMSTFBanner chart's image
Antibe Therapeutics
Price$0.22
Change+$0.03 (+15.79%)
Volume$33.94K
CapitalizationN/A
KADIMASTEM
Price$6.40
Change-$0.10 (-1.54%)
Volume$100
CapitalizationN/A
ATBPF vs KMSTF Comparison Chart
Loading...
View a ticker or compare two or three
VS
ATBPF vs. KMSTF commentary
Dec 12, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATBPF is a Buy and KMSTF is a Buy.

COMPARISON
Comparison
Dec 12, 2024
Stock price -- (ATBPF: $0.22 vs. KMSTF: $6.40)
Brand notoriety: ATBPF and KMSTF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATBPF: 100% vs. KMSTF: 100%
Market capitalization -- ATBPF: $11.43M vs. KMSTF: $14.58M
ATBPF [@Biotechnology] is valued at $11.43M. KMSTF’s [@Biotechnology] market capitalization is $14.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $489.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.72B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATBPF’s FA Score shows that 0 FA rating(s) are green whileKMSTF’s FA Score has 0 green FA rating(s).

  • ATBPF’s FA Score: 0 green, 5 red.
  • KMSTF’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATBPF and KMSTF are a bad buy in the long-term.

Price Growth

ATBPF (@Biotechnology) experienced а 0.00% price change this week, while KMSTF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.49%. For the same industry, the average monthly price growth was -4.71%, and the average quarterly price growth was +10.97%.

Industries' Descriptions

@Biotechnology (+0.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
KMSTF($14.6M) has a higher market cap than ATBPF($11.4M). KMSTF YTD gains are higher at: -1.477 vs. ATBPF (-68.387).
ATBPFKMSTFATBPF / KMSTF
Capitalization11.4M14.6M78%
EBITDAN/A-9.53M-
Gain YTD-68.387-1.4774,630%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ATBPF: Fundamental Ratings
ATBPF
OUTLOOK RATING
1..100
49
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
75
P/E GROWTH RATING
1..100
71
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATBPFKMSTF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
8%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
6%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PDP114.261.15
+1.02%
Invesco Dorsey Wright Momentum ETF
JPYUSD0.01N/A
N/A
Japan Yen - United States Dollar
CHFNZD1.95N/A
N/A
Switzerland Franc - New Zealand Dollar
GBPAUD2.00N/A
N/A
United Kingdom Pound - Australian Dollar
GMEYX12.04N/A
N/A
GuideStone Funds Impact Equity Instl

ATBPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATBPF has been loosely correlated with IRON. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ATBPF jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATBPF
1D Price
Change %
ATBPF100%
N/A
IRON - ATBPF
53%
Loosely correlated
-2.28%
KMSTF - ATBPF
52%
Loosely correlated
N/A
SRZN - ATBPF
47%
Loosely correlated
-0.75%
CDIO - ATBPF
25%
Poorly correlated
+40.74%
BIOR - ATBPF
23%
Poorly correlated
+0.29%
More

KMSTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, KMSTF has been loosely correlated with IRON. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if KMSTF jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMSTF
1D Price
Change %
KMSTF100%
N/A
IRON - KMSTF
54%
Loosely correlated
-2.28%
ATBPF - KMSTF
52%
Loosely correlated
N/A
ZVRA - KMSTF
30%
Poorly correlated
-0.67%
ACUT - KMSTF
28%
Poorly correlated
-10.37%
SRZN - KMSTF
28%
Poorly correlated
-0.75%
More